GlaxoSmithKline's CFO, Simon Dingemans, discusses sales growth and strong cash generation in the third quarter, research and development activity, as well as emerging markets and China.
GlaxoSmithKline's CFO on Q3 and Emerging Markets Business
GlaxoSmithKline's CFO, Simon Dingemans, discusses sales growth and strong cash generation in the third quarter, research and development activity, as well as emerging markets and China.
Oct 23, 2013